JAK3-IN-11 is a potent, non-cytotoxic, irreversible, and orally active JAK3 inhibitor with an IC50 of 1.7 nM and high selectivity (>588-fold over other JAK family members). It covalently binds to the ATP-binding pocket of JAK3, strongly inhibits JAK3-dependent signal transduction and T-cell proliferation, and serves as a valuable tool for studying autoimmune diseases.